AI Article Synopsis
- A 52-year-old Caucasian patient with relapsing-remitting multiple sclerosis developed an unclassified skin cancer, a rare occurrence among patients treated with fingolimod.
- This patient had no history of melanoma, minimal skin lesions, and limited sun exposure, making her case unique compared to typical melanoma cases reported in other studies.
- The overall incidence of skin cancer in multiple sclerosis patients is low, but recent cases emphasize the need for enhanced dermatological monitoring for these individuals.
Article Abstract
In addition to the TRANSFORMS, FREEDOMS, INFORMS studies, very few publications have identified new cases of skin cancer in patients treated with fingolimod. Here, we present the case of a 52-year-old Caucasian patient with relapsing remitting multiple sclerosis for 19 years, with a phototype II with blue eyes, light brown hair, no personal or family history of melanoma and a low number of naevi (<10). She did not experience intense sun exposure in childhood as well as severe sunburn and did not practise sessions in ultraviolet cabins. This case is distinguished from other published cases, usually superficial spreading malignant melanoma by its unclassifiable histological character. The occurrence of skin cancers in patients with multiple sclerosis remains exceptional, but new cases have recently emerged requiring the strengthening of dermatological follow-up of such patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506067 | PMC |
| http://dx.doi.org/10.1136/bcr-2018-227951 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!